BMC chemistry
BMC Chem
· ISSN (e) 2661-801X
· 1 paper in corpus
Elagolix (ELX) is an orally administered non-peptidic GnRH antagonist that has been approved by the Food and Drug Administration in 2018 for the treatment of endometriosis pain. A sensitive and selective method for estimating elagolix (ELX)…